Selected single-nucleotide polymorphisms inFOXE1,SERPINA5,FTO,EVPL,TICAM1andSCARB1are associated with papillary and follicular thyroid cancer risk: replication study in a German population
Authors:
- Alice J. SigurdsonASAlice J. Sigurdson
- Alina V. BrennerABAlina V. Brenner
- James A. RoachJRJames A. Roach
- Melissa BraganzaMBMelissa Braganza
Open Access
- 28 April 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 37 (7) , 677-684
Abstract
Several single-nucleotide polymorphisms (SNPs) have been associated with papillary and follicular thyroid cancer (PTC and FTC, respectively) risk, but few have replicated. After analyzing 17525 tag SNPs in 1129 candidate genes, we found associations with PTC risk in SERPINA5, FTO, HEMGN (near FOXE1) and other genes. Here, we report results from a replication effort in a large independent PTC/FTC case–control study conducted in Germany. We evaluated the best tagging SNPs from our previous PTC study and additionally included SNPs in or near FOXE1 and NKX2-1 genes, known susceptibility loci for thyroid cancer. We genotyped 422 PTC and 130 FTC cases and 752 controls recruited from three German clinical centers. We used polytomous logistic regression to simultaneously estimate PTC and FTC associations for 79 SNPs based on log-additive models. We assessed effect modification by body mass index (BMI), gender and age for all SNPs, and selected SNP by SNP interactions. We confirmed associations with PTC and SNPs in FOXE1/HEMGN, SERPINA5 (rs2069974), FTO (rs8047395), EVPL (rs2071194), TICAM1 (rs8120) and SCARB1 (rs11057820) genes. We found associations with SNPs in FOXE1, SERPINA5, FTO, TICAM1 and HSPA6 and FTC. We found two significant interactions between FTO (rs8047395) and BMI (P = 0.0321) and between TICAM1 (rs8120) and FOXE1 (rs10984377) (P = 0.0006). Besides the known associations with FOXE1 SNPs, we confirmed additional PTC SNP associations reported previously. We also found several new associations with FTC risk and noteworthy interactions. We conclude that multiple variants and host factors might interact in complex ways to increase risk of PTC and FTC.Keywords
Funding Information
- National Cancer Institute
- National Institutes of Health
This publication has 39 references indexed in Scilit:
- Common Genetic Variants in Sex Hormone Pathway Genes and Papillary Thyroid Cancer RiskThyroid®, 2012
- Common genetic variants in the 8q24 region and risk of papillary thyroid cancerThe Laryngoscope, 2012
- Family history of cancer and risk of sporadic differentiated thyroid carcinomaCancer, 2011
- Common genetic variants related to genomic integrity and risk of papillary thyroid cancerCarcinogenesis, 2011
- Obesity and Thyroid Cancer Risk among U.S. Men and Women: A Pooled Analysis of Five Prospective StudiesCancer Epidemiology, Biomarkers & Prevention, 2011
- Exposing the Thyroid to Radiation: A Review of Its Current Extent, Risks, and ImplicationsEndocrine Reviews, 2010
- The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription FactorsPLOS Genetics, 2009
- Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005Cancer Epidemiology, Biomarkers & Prevention, 2009
- Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populationsNature Genetics, 2009
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006